RNS Number : 9430C
Mears Group PLC
28 February 2022
(the "Group" or the "Company")
Contract award - Residential Living Accommodation Project
Neville Registrars is delighted to welcome Cizzle Biotechnology Holdings PLC as the newest addition to its list of client companies.
Cizzle Biotechnology is a cancer diagnostics spin-out from the University of York.
Further information can be found on the Company's website: https://cizzlebiotechnology.com/
RNS Number : 2039C
Immotion Group PLC
21 February 2022
Immotion Group plc
("Immotion", the "Company" or the "Group")
Shark Reef Aquarium Expansion and Contract Extension, and Trading Update
Shark Reef Aquarium E
RNS Number : 2163B
Crimson Tide PLC
10 February 2022
10 February 2022
Crimson Tide Plc
("Crimson Tide" or "the Company")
Significant Contract Win and New Partnership
Crimson Tide Plc (TIDE) is delighted to announce both
RNS Number : 4554A
Solid State PLC
03 February 2022
Reach - non regulatory announcement
Solid State plc
( "Solid State", the " Group " or the "Company" )
£ Multi-million contrac
RNS Number : 5117A
NetScientific PLC
02 February 2022
NetScientific plc
("NetScientific", the "Group" or the "Company")
PDS Phase 2 Trial Update
PDS Biotech Announces Preliminary Efficacy Achievement
RNS Number : 9106Z
ACP Energy PLC
28 January 2022
28 January 2022
ACP ENERGY PLC
("ACP" or "the Company")
Admission to Trading on London Stock Exchange & First Day of Dealings
<Neville Registrars is delighted to welcome ACP Energy Plc as the newest addition to its list of client companies.
ACP Energy will focus on producing assets that are either in production or near production to ensure swift cash flow generation and stability to the business.
Further information can be found on the Company's website: https://acpenergyplc.com/
RNS Number : 7773Z
Shearwater Group PLC
27 January 2022
27 January 2022
RNS Reach
Shearwater Group PLC
("Shearwater", or the "Group")
Contract Renewals
Brookcourt Solutions <
RNS Number : 4127Z
N4 Pharma PLC
25 January 2022
25 January 2022
N4 Pharma Plc
("N4 Pharma" or the "Company")
Oncology work programme update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a nove